Reaction
Rectal Perforation reporting signals
As of the last recalculation, Rectal Perforation appears in 533 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is DAPTOMYCIN (PRR 56.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Daptomycin | 13 | 56.4 | 56.5 |
| Bevacizumab | 127 | 52.3 | 52.3 |
| Oxaliplatin | 62 | 36.8 | 36.8 |
| Irinotecan Hydrochloride | 11 | 34.1 | 34.1 |
| Leucovorin Calcium | 16 | 33.7 | 33.7 |
| Fluorouracil Cream, 0.5% | 55 | 31.3 | 31.3 |
| Fluorouracil | 55 | 30.8 | 30.9 |
| Capecitabine | 45 | 20.9 | 20.9 |
| Lenvatinib | 17 | 20.9 | 20.9 |
| Panitumumab | 8 | 20.2 | 20.2 |
| Linezolid | 15 | 20.2 | 20.2 |
| Paclitaxel (Aibumin-Bound) | 35 | 17.7 | 17.7 |
| Paclitaxel | 37 | 15.6 | 15.6 |
| Trifluridine And Tipiracil | 4 | 14.7 | 14.7 |